Evolution of Plasmodium falciparum drug resistance: Implications for the development and containment of artemisinin resistance

Japanese Journal of Infectious Diseases

Volumn 65, Issue 6, 2012, Pages 465-475

  Mita, Toshihiro ^a,b   Tanabe, Kazuyuki ^c,d  

^a JUNTENDO UNIVERSITY   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^c OSAKA UNIVERSITY   (Japan)

^d OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTEETHER; ARTEMETHER; ARTEMETHER PLUS AMODIAQUINE; ARTEMETHER PLUS BENFLUMETOL; ARTEMISIN; ARTEMISININ DERIVATIVE; ARTESUNATE; ARTESUNATE PLUS MEFLOQUINE; CHLOROQUINE; DIHYDROFOLATE REDUCTASE; PYRIMETHAMINE; PYRIMETHAMINE PLUS SULFADOXINE; SULFADOXINE; UNCLASSIFIED DRUG;

AFRICA; ANOPHELES; ANTIMALARIAL DRUG RESISTANCE; ANTIMALARIAL DRUG SUSCEPTIBILITY; CAMBODIA; COMBINATION CHEMOTHERAPY; DHFR GENE; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG MECHANISM; DRUG STRUCTURE; GENE; GEOGRAPHIC DISTRIBUTION; HEALTH CARE POLICY; HUMAN; IC 50; MALARIA FALCIPARUM; MOLECULAR EVOLUTION; NONHUMAN; PARASITE CLEARANCE; PFCRT GENE; PLASMODIUM (LIFE CYCLE STAGE); PLASMODIUM FALCIPARUM; POPULATION GENETICS; REVIEW; SOUTHEAST ASIA; THAILAND;

AFRICA; ANTIMALARIALS; ARTEMISININS; ASIA, SOUTHEASTERN; BIOLOGICAL EVOLUTION; CHLOROQUINE; DRUG COMBINATIONS; DRUG RESISTANCE; GENE FLOW; HUMANS; PLASMODIUM FALCIPARUM; PYRIMETHAMINE; SOUTH AMERICA; SULFADOXINE;

EID: 84869746661     PISSN: 13446304     EISSN: 18842836     Source Type: Journal    
DOI: 10.7883/yoken.65.465     Document Type: Review

References (109)

1. World Health Organization (2011): World Malaria Report 2011.
2. Mita, T., Tanabe, K. and Kita, K. (2009): Spread and evolution of Plasmodium falciparum drug resistance. Parasitol. Int., 58, 201-209.
3. Enserink, M. (2007): Combating malaria. Malaria treatment: ACT two. Science, 318, 560-563.
4. Gregson, A. and Plowe, C.V. (2005): Mechanisms of resistance of malaria parasites to antifolates. Pharmacol. Rev., 57, 117-145.
5. Ekland, E.H. and Fidock, D.A. (2007): Advances in understanding the genetic basis of antimalarial drug resistance. Curr. Opin. Microbiol., 10, 363-370.
6. Wootton, J.C., Feng, X., Ferdig, M.T., et al. (2002): Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum. Nature, 418, 320-323.
7. Nair, S., Williams, J.T., Brockman, A., et al. (2003): A selective sweep driven by pyrimethamine treatment in Southeast Asian malaria parasites. Mol. Biol. Evol., 20, 1526-1536.
8. Roper, C., Pearce, R., Nair, S., et al. (2004): Intercontinental spread of pyrimethamine-resistant malaria. Science, 305, 1124.
9. McCollum, A.M., Poe, A.C., Hamel, M., et al. (2006): Antifolate resistance in Plasmodium falciparum: multiple origins and identification of novel dhfr alleles. J. Infect. Dis., 194, 189-197.
10. Mita, T., Tanabe, K., Takahashi, N., et al. (2007): Independent evolution of pyrimethamine resistance in Plasmodium falciparum isolates in Melanesia. Antimicrob. Agents Chemother., 51, 1071-1077.
11. McCollum, A.M., Basco, L.K., Tahar, R., et al. (2008): Hitchhiking and selective sweeps of Plasmodium falciparum sulfadoxine and pyrimethamine resistance alleles in a population from central Africa. Antimicrob. Agents Chemother., 52, 4089-4097.
12. Mita, T., Tanabe, K., Takahashi, N., et al. (2009): Indigenous evolution of Plasmodium falciparum pyrimethamine resistance multiple times in Africa. J. Antimicrob. Chemother., 63, 252-255.
13. Mita, T., Venkatesan, M., Ohashi, J., et al. (2011): Limited geographical origin and global spread of sulfadoxine-resistant dhps alleles in Plasmodium falciparum Populations. J. Infect. Dis., 204, 1980-1988.
14. Yayon, A., Cabantchik, Z.I. and Ginsburg, H. (1984): Identification of the acidic compartment of Plasmodium falciparuminfected human erythrocytes as the target of the antimalarial drug chloroquine. EMBO J., 3, 2695-2700.
15. Sullivan, D.J., Jr., Gluzman, I.Y., Russell, D.G., et al. (1996): On the molecular mechanism of chloroquine's antimalarial action. Proc. Natl. Acad. Sci. USA, 93, 11865-11870.
16. Bray, P.G., Mungthin, M., Ridley, R.G., et al. (1998): Access to hematin: the basis of chloroquine resistance. Mol. Pharmacol., 54, 170-179.
17. Pisciotta, J.M. and Sullivan, D. (2008): Hemozoin: oil versus water. Parasitol. Int., 57, 89-96.
18. Fitch, C.D. (1969): Chloroquine resistance in malaria: a deficiency of chloroquine binding. Proc. Natl. Acad. Sci. USA, 64, 1181-1187.
19. Krogstad, D.J., Gluzman, I.Y., Kyle, D.E., et al. (1987): Efflux of chloroquine from Plasmodium falciparum: mechanism of chloroquine resistance. Science, 238, 1283-1285.
20. Saliba, K.J., Folb, P.I. and Smith, P.J. (1998): Role for the Plasmodium falciparum digestive vacuole in chloroquine resistance. Biochem. Pharmacol., 56, 313-320.
21. Fidock, D.A., Nomura, T., Talley, A.K., et al. (2000): Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol. Cell, 6, 861-871.
22. Cooper, R.A., Lane, K.D., Deng, B., et al. (2007): Mutations in transmembrane domains 1, 4 and 9 of the Plasmodium falciparum chloroquine resistance transporter alter susceptibility to chloroquine, quinine and quinidine. Mol. Microbiol., 63, 270-282.
23. Martin, R.E., Marchetti, R.V., Cowan, A.I., et al. (2009): Chloroquine transport via the malaria parasite's chloroquine resistance transporter. Science, 325, 1680-1682.
24. Roepe, P.D. (2011): PfCRT-mediated drug transport in malarial parasites. Biochemistry, 50, 163-171.
25. Sanchez, C.P., Stein, W. and Lanzer, M. (2003): Trans stimulation provides evidence for a drug efflux carrier as the mechanism of chloroquine resistance in Plasmodium falciparum. Biochemistry, 42, 9383-9394.
26. Sanchez, C.P., McLean, J.E., Rohrbach, P., et al. (2005): Evidence for a pfcrt-associated chloroquine efflux system in the human malarial parasite Plasmodium falciparum. Biochemistry, 44, 9862-9870.
27. Bray, P.G., Martin, R.E., Tilley, L., et al. (2005): Defining the role of PfCRT in Plasmodium falciparum chloroquine resistance. Mol. Microbiol., 56, 323-333.
28. Bzik, D.J., Li, W.B., Horii, T., et al. (1987): Molecular cloning and sequence analysis of the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene. Proc. Natl. Acad. Sci. USA, 84, 8360-8364.
29. Brooks, D.R., Wang, P., Read, M., et al. (1994): Sequence variation of the hydroxymethyldihydropterin pyrophosphokinase: dihydropteroate synthase gene in lines of the human malaria parasite, Plasmodium falciparum, with differing resistance to sulfadoxine. Eur. J. Biochem., 224, 397-405.
30. Triglia, T. and Cowman, A.F. (1994): Primary structure and expression of the dihydropteroate synthetase gene of Plasmodium falciparum. Proc. Natl. Acad. Sci. USA, 91, 7149-7153.
31. Cowman, A.F., Morry, M.J., Biggs, B.A., et al. (1988): Amino acid changes linked to pyrimethamine resistance in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum. Proc. Natl. Acad. Sci. USA, 85, 9109-9113.
32. Peterson, D.S., Walliker, D. and Wellems, T.E. (1988): Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria. Proc. Natl. Acad. Sci. USA, 85, 9114-9118.
33. Sirawaraporn, W., Sathitkul, T., Sirawaraporn, R., et al. (1997): Antifolate-resistant mutants of Plasmodium falciparum dihydrofolate reductase. Proc. Natl. Acad. Sci. USA, 94, 1124-1129.
34. Lozovsky, E.R., Chookajorn, T., Brown, K.M., et al. (2009): Stepwise acquisition of pyrimethamine resistance in the malaria parasite. Proc. Natl. Acad. Sci. USA, 106, 12025-12030.
35. Brown, K.M., Costanzo, M.S., Xu, W., et al. (2010): Compensatory mutations restore fitness during the evolution of dihydrofolate reductase. Mol. Biol. Evol., 27, 2682-2690.
36. Triglia, T., Menting, J.G., Wilson, C., et al. (1997): Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum. Proc. Natl. Acad. Sci. USA, 94, 13944-13949.
37. de Beer, T.A., Louw, A.I. and Joubert, F. (2006): Elucidation of sulfadoxine resistance with structural models of the bifunctional Plasmodium falciparum dihydropterin pyrophosphokinase-dihydropteroate synthase. Bioorg. Med. Chem., 14, 4433-4443.
38. Vinayak, S., Alam, M.T., Mixson-Hayden, T., et al. (2010): Origin and evolution of sulfadoxine resistant Plasmodium falciparum. PLoS Pathog., 6, e1000830.
39. Alam, M.T., de Souza, D.K., Vinayak, S., et al. (2011): Selective sweeps and genetic lineages of Plasmodium falciparum drug-resistant alleles in Ghana. J. Infect. Dis., 203, 220-227.
40. Alam, M.T., Vinayak, S., Congpuong, K., et al. (2011): Tracking origins and spread of sulfadoxine-resistant Plasmodium falciparum dhps alleles in Thailand. Antimicrob. Agents Chemother., 55, 155-164.
41. Barnes, K.I., Little, F., Mabuza, A., et al. (2008): Increased gametocytemia after treatment: an early parasitological indicator of emerging sulfadoxine-pyrimethamine resistance in falciparum malaria. J. Infect. Dis., 197, 1605-1613.
42. Stepniewska, K., Price, R.N., Sutherland, C.J., et al. (2008): Plasmodium falciparum gametocyte dynamics in areas of different malaria endemicity. Malar. J., 7, 249.
43. Dondorp, A.M., Yeung, S., White, L., et al. (2010): Artemisinin resistance: current status and scenarios for containment. Nat. Rev. Microbiol., 8, 272-280.
44. Olatunde, A. (1977): Chloroquine-resistant Plasmodium falciparum and malaria in Africa. Trans. R. Soc. Trop. Med. Hyg., 71, 80-81.
45. Campbell, C.C., Chin, W., Collins, W.E., et al. (1979): Chloroquine-resistant Plasmodium falciparum from East Africa: cultivation and drug sensitivity of the Tanzanian I/CDC strain from an American tourist. Lancet, 2, 1151-1154.
46. Fogh, S., Jepsen, S. and Effersoe, P. (1979): Chloroquineresistant Plasmodium falciparum malaria in Kenya. Trans. R. Soc. Trop. Med. Hyg., 73, 228-229.
47. Khan, A.A. and Maguire, M.J. (1978): Relative chloroquine resistance of P. falciparum in Zambia. Br. Med. J., 1, 1669-1670.
48. Fogh, S., Jepsen, S. and Mataya, R.H. (1984): R-III chloroquine-resistant Plasmodium falciparum malaria from northern Malawi. Trans. R. Soc. Trop. Med. Hyg., 78, 282.
49. Moran, J.S. (1983): Failure of chloroquine prophylaxis in Plasmodium falciparum in Zaire. Lancet, 2, 171-172.
50. Sansonetti, P.J., Lebras, C., Verdier, F., et al. (1985): Chloroquine-resistant Plasmodium falciparum in Cameroon. Lancet, 1, 1154-1155.
51. Simon, F., Le Bras, J., Charmot, G., et al. (1986): Severe chloroquine-resistant falciparum malaria in Gabon with decreased sensitivity to quinine. Trans. R. Soc. Trop. Med. Hyg., 80, 996-997.
52. Menon, A., Snow, R.W., Otoo, L., et al. (1987): Decline in sensitivity of Plasmodium falciparum to chloroquine in The Gambia. Lancet, 1, 1029-1030.
53. Charmot, G., Le Bras, J., Doury, J.C., et al. (1988): Chloroquine-resistant Plasmodium falciparum malaria from Ivory Coast. Trans. R. Soc. Trop. Med. Hyg., 82, 392-393.
54. Huige, W.M. and Sligcher, P. (1988): A study on chloroquine resistant falciparum malaria in a rural population in Ghana. Trop. Geogr. Med., 40, 174-175.
55. Trape, J.F., Legros, F., Ndiaye, P., et al. (1989): Chloroquineresistant Plasmodium falciparum malaria in Senegal. Trans. R. Soc. Trop. Med. Hyg., 83, 761.
56. Mehlotra, R.K., Mattera, G., Bockarie, M.J., et al. (2008): Discordant patterns of genetic variation at two chloroquine resistance loci in worldwide populations of the malaria parasite Plasmodium falciparum. Antimicrob. Agents Chemother., 52, 2212-2222.
57. Takahashi, N., Tanabe, K., Tsukahara, T., et al. (2012): Largescale survey for novel genotypes of Plasmodium falciparum chloroquine-resistance gene pfcrt. Malar. J., 11, 92.
58. Contreras, C.E., Cortese, J.F., Caraballo, A., et al. (2002): Genetics of drug-resistant Plasmodium falciparum malaria in the Venezuelan state of Bolivar. Am. J. Trop. Med. Hyg., 67, 400-405.
59. Vieira, P.P., Ferreira, M.U., Alecrim, M.G., et al. (2004): pfcrt Polymorphism and the spread of chloroquine resistance in Plasmodium falciparum populations across the Amazon Basin. J. Infect. Dis., 190, 417-424.
60. Maiga, O., Djimde, A.A., Hubert, V., et al. (2007): A shared Asian origin of the triple-mutant dhfr allele in Plasmodium falciparum from sites across Africa. J. Infect. Dis., 196, 165-172.
61. McCollum, A.M., Mueller, K., Villegas, L., et al. (2007): Common origin and fixation of Plasmodium falciparum dhfr and dhps mutations associated with sulfadoxine-pyrimethamine resistance in a low-transmission area in South America. Antimicrob. Agents Chemother., 51, 2085-2091.
62. Mita, T. (2010): Origins and spread of pfdhfr mutant alleles in Plasmodium falciparum. Acta Trop., 114, 166-170.
63. Certain, L.K., Briceno, M., Kiara, S.M., et al. (2008): Characteristics of Plasmodium falciparum dhfr haplotypes that confer pyrimethamine resistance, Kilifi, Kenya, 1987-2006. J. Infect. Dis., 197, 1743-1751.
64. Saito-Nakano, Y., Tanabe, K. and Mita, T. (2011): Identification of pyrimethamine-and chloroquine-resistant Plasmodium falciparum in Africa between 1984 and 1998: genotyping of archive blood samples. Malar. J., 10, 388.
65. Hill, J. (1963): Chemotherapy of malaria. p. 513-601. In Schnitzer, R. and Hawkings, F. (eds.), The Antimalarial Drugs, in Experimental Chemotherapy. Academic Press, New York. 1963:
66. Bjorkman, A. and Phillips-Howard, P.A. (1990): The epidemiology of drug-resistant malaria. Trans. R. Soc. Trop. Med. Hyg., 84, 177-180.
67. Wongsrichanalai, C., Pickard, A.L., Wernsdorfer, W.H., et al. (2002): Epidemiology of drug-resistant malaria. Lancet Infect. Dis., 2, 209-218.
68. Zhou, Z., Griffing, S.M., de Oliveira, A.M., et al. (2008): Decline in sulfadoxine-pyrimethamine-resistant alleles after change in drug policy in the Amazon region of Peru. Antimicrob. Agents Chemother., 52, 739-741.
69. Pearce, R.J., Pota, H., Evehe, M.S., et al. (2009): Multiple origins and regional dispersal of resistant dhps in African Plasmodium falciparum malaria. PLoS Med., 6, e1000055.
70. Miller, L.H. and Su, X. (2011): Artemisinin: discovery from the Chinese herbal garden. Cell, 146, 855-858.
71. Group, Q.A.C.R. (1979): Antimalaria studies on Qinghaosu. Chin. Med. J. (Engl)., 92, 811-816.
72. White, N.J. (2008): Qinghaosu (artemisinin): the price of success. Science, 320, 330-334.
73. Pukrittayakamee, S., Chotivanich, K., Chantra, A., et al. (2004): Activities of artesunate and primaquine against asexualand sexual-stage parasites in falciparum malaria. Antimicrob. Agents Chemother., 48, 1329-1334.
74. Okell, L.C., Drakeley, C.J., Ghani A.C., et al. (2008): Reduction of transmission from malaria patients by artemisinin combination therapies: a pooled analysis of six randomized trials. Malar. J., 7, 125.
75. White, N.J. (1997): Assessment of the pharmacodynamic properties of antimalarial drugs in vivo. Antimicrob. Agents Chemother., 41, 1413-1422.
76. White, N.J., Pongtavornpinyo, W., Maude, R.J., et al. (2009): Hyperparasitaemia and low dosing are an important source of anti-malarial drug resistance. Malar. J., 8, 253.
77. Price, R., van Vugt, M., Nosten, F., et al. (1998): Artesunate versus artemether for the treatment of recrudescent multidrugresistant falciparum malaria. Am. J. Trop. Med. Hyg., 59, 883-888.
78. White, N.J. and Olliaro, P.L. (1996): Strategies for the prevention of antimalarial drug resistance: rationale for combination chemotherapy for malaria. Parasitol. Today, 12, 399-401.
79. White, N.J. (2004): Antimalarial drug resistance. J. Clin. Invest., 113, 1084-1092.
80. Ding, X.C., Beck, H.P. and Raso, G. (2011): Plasmodium sensitivity to artemisinins: magic bullets hit elusive targets. Trends Parasitol., 27, 73-81.
81. Luxemburger, C., Brockman, A., Silamut, K., et al. (1998): Two patients with falciparum malaria and poor in vivo responses to artesunate. Trans. R. Soc. Trop. Med. Hyg., 92, 668-669.
82. Gogtay, N.J., Kadam, V.S., Karnad, D.R., et al. (2000): Probable resistance to parenteral artemether in Plasmodium falciparum: case reports from Mumbai (Bombay), India. Ann. Trop. Med. Parasitol., 94, 519-520.
83. Sahr, F., Willoughby, V.R., Gbakima, A.A., et al. (2001): Apparent drug failure following artesunate treatment of Plasmodium falciparum malaria in Freetown, Sierra Leone: four case reports. Ann. Trop. Med. Parasitol., 95, 445-449.
84. Noedl, H. (2005): Artemisinin resistance: how can we find it? Trends Parasitol., 21, 404-405.
85. Hien, T.T. and White, N.J. (1993): Qinghaosu. Lancet, 341, 603-608.
86. Newton, P., Proux, S., Green, M., et al. (2001): Fake artesunate in southeast Asia. Lancet, 357, 1948-1950.
87. Noedl, H., Se, Y., Schaecher, K., et al. (2008): Evidence of artemisinin-resistant malaria in western Cambodia. N. Engl. J. Med., 359, 2619-2620.
88. Rogers, W.O., Sem, R., Tero, T., et al. (2009): Failure of artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria in southern Cambodia. Malar. J., 8, 10.
89. Carrara, V.I., Zwang, J., Ashley, E.A., et al. (2009): Changes in the treatment responses to artesunate-mefloquine on the northwestern border of Thailand during 13 years of continuous deployment. PLoS One, 4, e4551.
90. Yang, H., Liu, D., Yang, Y., et al. (2003): Changes in susceptibility of Plasmodium falciparum to artesunate in vitro in Yunnan Province, China. Trans. R. Soc. Trop. Med. Hyg., 97, 226-228.
91. Phyo, A.P., Nkhoma, S., Stepniewska, K., et al. (2012): Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study. Lancet, 379, 1960-1966.
92. Saralamba, S., Pan-Ngum, W., Maude, R.J., et al. (2011): Intrahost modeling of artemisinin resistance in Plasmodium falciparum. Proc. Natl. Acad. Sci. USA, 108, 397-402.
93. Cheeseman, I.H., Miller, B.A., Nair, S., et al. (2012): A major genome region underlying artemisinin resistance in malaria. Science, 336, 79-82.
94. Cui, L., Yan, G., Sattabongkot, J., et al. (2011): Malaria in the Greater Mekong subregion: heterogeneity and complexity. Acta Trop., 121, 227-239.
95. Verdrager, J. (1986): Epidemiology of the emergence and spread of drug-resistant falciparum malaria in South-East Asia and Australasia. J. Trop. Med. Hyg., 89, 277-289.
96. Dondorp, A.M., Nosten, F., Yi, P., et al. (2009): Artemisinin resistance in Plasmodium falciparum malaria. N. Engl. J. Med., 361, 455-467.
97. Mackinnon, M.J. (2005): Drug resistance models for malaria. Acta Trop., 94, 207-217.
98. Hastings, I.M. (2004): The origins of antimalarial drug resistance. Trends Parasitol., 20, 512-518.
99. Anderson, T.J., Haubold, B., Williams, J.T., et al. (2000): Microsatellite markers reveal a spectrum of population structures in the malaria parasite Plasmodium falciparum. Mol. Biol. Evol., 17, 1467-1482.
100. Iwagami, M., Rivera, P.T., Villacorte, E.A., et al. (2009): Genetic diversity and population structure of Plasmodium falciparum in the Philippines. Malar. J., 8, 96.
101. Wright, S. (1952): The theoretical variance within and among subdivisions of a population that is in a steady state. Genetics, 37, 312-321.
102. Hanski, I.A. and Simberloff, D. (1997): The Metapopulation Approach, Its History, Conceptual Domain and Application to Conservation. p. 5-26. In Hanski, I.A. and Gilpin, M.E. (eds.), Metapopulation Biology: Ecology, Genetics, and Evolution. Academic Press, San Diego.
103. Ariey, F., Duchemin, J.B. and Robert, V. (2003): Metapopulation concepts applied to falciparum malaria and their impacts on the emergence and spread of chloroquine resistance. Infect. Genet. Evol., 2, 185-192.
104. Rathod, P.K., McErlean, T. and Lee, P.C. (1997): Variations in frequencies of drug resistance in Plasmodium falciparum. Proc. Natl. Acad. Sci. USA, 94, 9389-9393.
105. Castellini, M.A., Buguliskis, J.S., Casta, L.J., et al. (2011): Malaria drug resistance is associated with defective DNA mismatch repair. Mol. Biochem. Parasitol., 177, 143-147.
106. World Health Organization (2011): Global Plan for Artemisinin Resistance Containment 2011.
107. Yeung, S. and White, N.J. (2005): How do patients use antimalarial drugs? A review of the evidence. Trop. Med. Int. Health, 10, 121-138.
108. Dittrich, S., Mitchell, S.L., Blagborough, A.M., et al. (2008): An atypical orthologue of 6-pyruvoyltetrahydropterin synthase can provide the missing link in the folate biosynthesis pathway of malaria parasites. Mol. Microbiol., 67, 609-618.
109. Nair, S., Miller, B., Barends, M., et al. (2008): Adaptive copy number evolution in malaria parasites. PLoS Genet., 4, e1000243.